Julian Baker, Director at Neoleukin Therapeutics, Inc. (NLTX), bought 424,000 shares at $15.25 ($6.5M) on 2020-07-07, disclosed to the SEC on 2020-12-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.25 | 29,640 | $452K | 7.0% |
| 2 | $15.25 | 394,360 | $6.0M | 93.0% |
| Total | $15.25 avg | 424,000 | $6.5M | 100% |
| Filing → |
| MDGL | BUY | 2023-11-15 | $15.6M | — | Filing → |
| BCEL | SELL | 2023-10-23 | $211K | — | Filing → |
| IGMS | BUY | 2023-06-28 | $45.0M | — | Filing → |